Breaking News

NSF Acquires IPEC Auditing Arm

By Kristin Brooks | February 10, 2014

Adds auditing and certification of excipients

NSF International has acquired the auditing subsidiary of the International Pharmaceutical Excipients Council of the Americas (IPEA). NSF-IPEA can now provide excipient auditing and certification as part of NSF’s Health Sciences Pharma Biotech Division. Clients can also obtain excipient, food additive and dietary supplement ingredient audits from NSF.
 
The audits require excipients to be safe, functional, and to comply with GMP requirements. The excipient GMP certification program is accredited by the American National Standards Institute (ANSI), and offers third-party audits based on IPEC – PQG Good Manufacturing Practices Guide for Pharmaceutical Excipients and excipient GMP certification.
 
Additionally, NSF International is working with representatives from the chemical and pharma industries and the FDA to develop an NSF/ANSI excipient GMP consensus standard, which defines GMPs for excipient manufacture for use in drug products and specifies the components of a quality management system for excipient manufacture.
 
NSF Health Sciences Pharma Biotech vice president Janeen Skutnik-Wilkinson will lead the excipients program. Ms. Skutnik-Wilkinson has more than 20 years of experience in technical and regulatory support roles, including leadership positions with Pfizer, Merck and IPEC, where she played a key role in the creation of IPEA. 
 
“NSF International shares IPEA’s long-standing commitment to excipient safety. Our expertise in standards development and certification will help excipient manufacturers globally build credibility and save time and money by benefiting from bundled audits and streamlined certification services,” said Ms. Skutnik-Wilkinson.

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important